Therapeutic Asset Ratings

13,157 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Trastuzumab Emtansine Malignant Pancreatic Neoplasm	OHSU Knight Cancer Institute	P2	B (63)
Tucatinib Metastatic Neoplasm	QuantumLeap Healthcare Collaborative	P2	B (63)
Veliparib Malignant Pancreatic Neoplasm	National Cancer Institute (NCI)	P2	B (63)
Venetoclax B-Cell Non-Hodgkin Lymphoma	Nurix Therapeutics, Inc.	P2	B (63)
Venetoclax Myeloproliferative Neoplasm	Children's Hospital Medical Center, Cincinnati	P2	B (63)
Venetoclax T-Cell Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	P2	B (63)
(+)-VINCRISTINE Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P2	B (63)
(+)-VINCRISTINE B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma And Classical Hodgkin Lymphoma	City of Hope Medical Center	P2	B (63)
(+)-VINCRISTINE Neuroblastoma	Theodore Laetsch	P2	B (63)
Vismodegib Breast Carcinoma	OHSU Knight Cancer Institute	P2	B (63)
Vismodegib Breast Cancer	OHSU Knight Cancer Institute	P2	B (63)
XENON Asthma	University of Kansas Medical Center	P2	B (63)
Ziv-Aflibercept Ovarian Cancer	National Cancer Institute (NCI)	P2	B (63)
Ziv-Aflibercept Cutaneous Melanoma	National Cancer Institute (NCI)	P2	B (63)
18f-flt Acute Lymphoblastic Leukemia	University of Oklahoma	P2	B (62)
2 (1H))-QUINOLINONE,6-(AMINO(4-CHLOROPHENYL)(1-METHYL-1H-IMIDAZOL-5-YL)METHYL)-4-(3-CHLOROPHENYL)-1-METHYL-,(+)- Melanoma	National Cancer Institute (NCI)	P2	B (62)
Abemaciclib Ovarian Serous Adenocarcinoma	AstraZeneca	P2	B (62)
Acalabrutinib Primary Central Nervous System Lymphoma	Jonsson Comprehensive Cancer Center	P2	B (62)
Acalabrutinib Marginal Zone Lymphoma	Narendranath Epperla	P2	B (62)
Adavosertib Refractory Malignant Neoplasm	National Cancer Institute (NCI)	P2	B (62)
Allopurinol Acute Lymphoblastic Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (62)
Allopurinol Acute Undifferentiated Leukemia	Masonic Cancer Center, University of Minnesota	P2	B (62)
Allopurinol Leukemia	M.D. Anderson Cancer Center	P2	B (62)
Alpelisib Estrogen-Receptor Positive Breast Cancer	Jennifer Lee Caswell-Jin	P2	B (62)
.ALPHA.-1 PROTEASE INHIBITOR Pulmonary Emphysema	Sanofi	P2	B (62)

Showing 1101 to 1125 of 13,157 assets

PreviousPage 45 of 527Next